Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report)’s stock price was down 7.8% during mid-day trading on Wednesday . The stock traded as low as $3.90 and last traded at $3.90. Approximately 9,134 shares changed hands during trading, a decline of 90% from the average daily volume of 90,658 shares. The stock had previously closed at $4.23.
Qualigen Therapeutics Trading Down 3.5 %
The company has a fifty day moving average of $5.13 and a 200-day moving average of $8.42.
About Qualigen Therapeutics
Qualigen Therapeutics, Inc, a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints.
Featured Articles
- Five stocks we like better than Qualigen Therapeutics
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- About the Markup Calculator
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Trading Halts Explained
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
